Valuation: EMVision Medical Devices Ltd

Market Cap 140M 97.45M 85.25M 78.61M 72.74M 138M 9.3B 941M 369M 4.57B 366M 358M 15.82B P/E 2026 *
-15.4x
P/E 2027 * -13.4x
Enterprise Value 140M 97.45M 85.25M 78.61M 72.74M 138M 9.3B 941M 369M 4.57B 366M 358M 15.82B EV / Sales 2026 *
25.5x
EV / Sales 2027 * 28.1x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 day-0.66%
1 week-4.46%
Current month-0.99%
1 month-1.32%
3 months-3.54%
6 months-18.48%
Current year-15.73%
1 week 1.48
Extreme 1.485
1.58
1 month 1.47
Extreme 1.47
1.62
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.16
Extreme 1.155
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap.
04-23Buy

Director

10,000 0.0108%
01-02Expiration

Chairman

300,000 0.3228%
11-18Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%-4.46%-14.29%+32.74% 97.45M
+0.23%+1.50%+21.97%+1.64% 195B
-1.00%-5.29%-22.08%+20.47% 146B
-0.28%+0.50%-56.84%-14.94% 66.87B
-0.21%-4.39%+15.48%-0.70% 52.59B
+1.12%-0.49%-27.27%-29.99% 43.85B
+0.05%+2.60%+7.91%+13.21% 37.73B
+0.19%-0.01%+7.23%+43.14% 37.03B
-2.01%-6.03%-20.48%-5.26% 30.07B
-0.19%+0.25%-15.03%-19.41% 29.43B
Average -0.31%-1.70%-10.34%+4.09% 63.84B
Weighted average by Cap. -0.26%-1.81%-5.66%+3.64%

Financials

2026 *2027 *
Net sales 5.5M 3.82M 3.34M 3.08M 2.85M 5.41M 364M 36.89M 14.46M 179M 14.33M 14.02M 620M 5M 3.47M 3.04M 2.8M 2.59M 4.92M 331M 33.54M 13.15M 163M 13.03M 12.75M 564M
Net income -9.1M -6.32M -5.53M -5.1M -4.72M -8.95M -603M -61.03M -23.93M -296M -23.72M -23.2M -1.03B -12M -8.33M -7.29M -6.72M -6.22M -11.8M -795M -80.49M -31.55M -391M -31.28M -30.6M -1.35B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
10/07/26 A$1.500 -0.66% 31,574
09/07/26 A$1.510 +0.67% 19,373
08/07/26 A$1.500 -3.23% 11,402
07/07/26 A$1.550 -0.96% 5,726
06/07/26 A$1.565 -0.32% 16,527
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.510AUD
Average target price
3.150AUD
Spread / Average Target
+108.61%

Annual profits - Rate of surprise